BiotechTube
MassMatrix

MassMatrix

Columbus, United States· Est.
massmatrix.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

MassMatrix is a private biotechnology company providing a modern, cloud-based software platform to revolutionize mass spectrometry data analysis for biologics characterization. Its core product, mmBiologics, addresses key industry pain points through automation, vendor-neutral data integration, and user-friendly interfaces, accelerating R&D in gene therapy and protein therapeutics. The company has secured competitive NIH SBIR grants to advance its technology, indicating validation of its scientific approach, and operates on a business model combining product sales with bespoke data science services.

ProteomicsDiagnostics

Technology Platform

mmBiologics: A cloud-based software platform for automated mass spectrometry data analysis and characterization of proteins, peptides, oligonucleotides, RNA/DNA, and conjugates. It features automated workflows, vendor-neutral integration, advanced deconvolution, sequencing, and quantitation algorithms.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The rapid growth of complex biologics and gene therapies creates a expanding need for advanced characterization tools.
The shift towards vendor-agnostic, cloud-based lab software presents a chance to displace legacy systems.
Offering an affordable solution opens the academic and small biotech market segments.

Risk Factors

Facing intense competition from established instrument vendors who bundle software.
Scaling the business may require venture funding beyond grant money, potentially challenging its affordability model.
Achieving deep integration with diverse lab ecosystems is critical for adoption.

Competitive Landscape

Competes against legacy software from large mass spectrometry instrument vendors (e.g., Thermo Fisher, Waters, Sciex) and standalone bioinformatics software providers. Differentiators include a vendor-neutral, modern cloud platform, emphasis on automation/ease-of-use, and affordability targeting a broader customer base.

More companies in Biologics / Biosimilars →More companies in United States →